Concepedia

Sandra Vanegas

SV

Statistics

Publications

5

Citations

430

H-Index

5

Active since

2002

Affiliations

XOMA (United States)(Current)

Sandra Vanegas is an author at XOMA (United States) specializing in immunology, cell signaling, and medicine.

Publications per year

2002–2019

5

Publications

5

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

Vinay Bhaskar, Johnny Yin, Amer M. Mirza et al. · Atherosclerosis · 2011 · 224 citations

, , +17

Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice

Patricia D. Finn, David Rodríguez, Jill Kohler et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2019 · 79 citations · Full text

, , +16

Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.

William J. LaRochelle, Michael Jeffers, José R. F. Corvalán et al. · PubMed · 2002 · 64 citations

, , +17

Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1β Activity

Marina K. Roell, Hassan Issafras, Robert J. Bauer et al. · Journal of Biological Chemistry · 2010 · 42 citations · Full text

, , +17

XOMA 052, an anti‐IL‐1β monoclonal antibody, prevents IL‐1β‐mediated insulin resistance in 3T3‐L1 adipocytes

Masahisa Handa, Sandra Vanegas, Betty A. Maddux et al. · Obesity · 2013 · 21 citations

, , +17

1–5 of 5